Sort   by:  
 Page size 
Cancers overexpressing the ERBB2 oncogene are aggressive and associated with a poor prognosis. Trastuzumab is a ERBB2 specific recombinant antibody employed for the treatment of these diseases since it blocks ERBB2 signaling causing growth arrest and survival inhibition. While the effects of Trastuz...
ORGANISM(S): Homo sapiens (Human) 
2021-09-09 | PXD024276 | Pride
The AKT pathway is a major regulator of human pancreatic adenocarcinoma progression and a key pharmacological target. The mechanisms of adaptation to long-term silencing of AKT isoforms of human and mouse pancreatic adenocarcinoma cancer cells were studied.
ORGANISM(S): Homo sapiens (Human) 
2021-09-09 | PXD020673 | Pride
Sort   by:  
 Page size